UNSPSC 51282524: Cefalexin sodium

This classification denotes a cephalosporin antibiotic with the molecular structure C16H16N3O4S.NA, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, F78YJG0WXK chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2r)-2-amino-2-phenylacetyl)amino)-3-methyl-8-oxo-, sodium salt (1:1), (6r,7r)-, but more commonly known as cefalexin sodium, which bears US NIH Compound Identifier 27447.

European Medicines Agency schedules Cefalexin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13273MIG. Most nations, for tariff and trade purposes, schedule cefalexin sodium under HS 29419000. SMILES: CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3CCCCC3)N)SC1)C(=O)[O-].[NA+].

UNSPSC 51282524 Cefaloxin sodium is a Commodity code that maps poorly to recent state and local procurement activity. The four most-recent opportunities tagged under this code involve naloxone and drug deactivation systems, general medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals and OTC products — none of which are cefalosporin antibiotics. The code shows minimal relevant activity; state and local procurement for cefalexin sodium itself does not appear in the recent opportunities block.

The misalignment between the code's nominal scope and the recent solicitations suggests either tagging inconsistency in the source data or a significant mismatch between UNSPSC classification practice and actual purchasing patterns under this commodity code. Procurement professionals pursuing pharmaceutical supply contracts at the state or local level should verify the correct UNSPSC coding before targeting opportunities; the visible activity — emergency medical supplies, direct-to-manufacturer prescription programs, and cooperative purchasing of generic pharmaceuticals through MMCAP — falls outside the antibiotic-specific scope that cefalexin sodium implies.